ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanofi and Immunext Enter Into Agreement to Develop Treatments for Autoimmune Diseases
January 16, 2017Sanofi and ImmuNext, Inc., have announced an agreement focused on the development of a novel antibody with the potential to treat a range of autoimmune diseases including Lupus and Multiple Sclerosis. Under the terms of the agreement, ImmuNext will grant
Pharma Sources Insight January 2025
